인쇄하기
취소
|
The Ministry of Health and Welfare(MOHW) once again stressed it has put the best effort on improving the passing rate and minimizing the period of drug assessments for the health insurance benefit for new anticancer drugs.
It was a follow-up of the criticism arguing the registration rate of the National Health Insurance for domestic new anticancer drugs is low and it takes too long to get the ...